<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN" "archivearticle3.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.0 20040830//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.0?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">09-PONE-RA-15177R1</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0009723</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline"><subject>Genetics and Genomics/Genetics of Disease</subject><subject>Immunology/Immunomodulation</subject><subject>Rheumatology/Cartilage Biology and Osteoarthritis</subject></subj-group></article-categories><title-group><article-title>New Sequence Variants in HLA Class II/III Region Associated with Susceptibility to Knee Osteoarthritis Identified by Genome-Wide Association Study</article-title><alt-title alt-title-type="running-head">GWAS of Knee Osteoarthritis</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Nakajima</surname><given-names>Masahiro</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Takahashi</surname><given-names>Atsushi</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Kou</surname><given-names>Ikuyo</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Rodriguez-Fontenla</surname><given-names>Cristina</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Gomez-Reino</surname><given-names>Juan J.</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Furuichi</surname><given-names>Tatsuya</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Dai</surname><given-names>Jin</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><contrib contrib-type="author"><name><surname>Sudo</surname><given-names>Akihiro</given-names></name><xref ref-type="aff" rid="aff6"><sup>6</sup></xref></contrib><contrib contrib-type="author"><name><surname>Uchida</surname><given-names>Atsumasa</given-names></name><xref ref-type="aff" rid="aff6"><sup>6</sup></xref></contrib><contrib contrib-type="author"><name><surname>Fukui</surname><given-names>Naoshi</given-names></name><xref ref-type="aff" rid="aff7"><sup>7</sup></xref></contrib><contrib contrib-type="author"><name><surname>Kubo</surname><given-names>Michiaki</given-names></name><xref ref-type="aff" rid="aff8"><sup>8</sup></xref></contrib><contrib contrib-type="author"><name><surname>Kamatani</surname><given-names>Naoyuki</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Tsunoda</surname><given-names>Tatsuhiko</given-names></name><xref ref-type="aff" rid="aff9"><sup>9</sup></xref></contrib><contrib contrib-type="author"><name><surname>Malizos</surname><given-names>Konstantinos N.</given-names></name><xref ref-type="aff" rid="aff10"><sup>10</sup></xref><xref ref-type="aff" rid="aff11"><sup>11</sup></xref></contrib><contrib contrib-type="author"><name><surname>Tsezou</surname><given-names>Aspasia</given-names></name><xref ref-type="aff" rid="aff12"><sup>12</sup></xref></contrib><contrib contrib-type="author"><name><surname>Gonzalez</surname><given-names>Antonio</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Nakamura</surname><given-names>Yusuke</given-names></name><xref ref-type="aff" rid="aff13"><sup>13</sup></xref><xref ref-type="aff" rid="aff14"><sup>14</sup></xref></contrib><contrib contrib-type="author"><name><surname>Ikegawa</surname><given-names>Shiro</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>&#x0002a;</sup></xref></contrib></contrib-group><aff id="aff1"><label>1</label><addr-line>Laboratory for Bone and Joint Diseases, Center for Genomic Medicine, RIKEN, Tokyo, Japan</addr-line></aff><aff id="aff2"><label>2</label><addr-line>Laboratory for Statistical Analysis, Center for Genomic Medicine, RIKEN, Tokyo, Japan</addr-line></aff><aff id="aff3"><label>3</label><addr-line>Laboratorio Investigacion 10 and Rheumatology Unit, Hospital Clinico Universitario de Santiago, Santiago de Compostela, Spain</addr-line></aff><aff id="aff4"><label>4</label><addr-line>Department of Medicine, University of Santiago de Compostela, Santiago de Compostela, Spain</addr-line></aff><aff id="aff5"><label>5</label><addr-line>The Center of Diagnosis and Treatment for Joint Disease, Drum Tower Hospital Affiliated to Medical School of Nanjing University, Nanjing, China</addr-line></aff><aff id="aff6"><label>6</label><addr-line>Department of Orthopaedic Surgery, Mie University Faculty of Medicine, Mie, Japan</addr-line></aff><aff id="aff7"><label>7</label><addr-line>Department of Pathomechanisms, Clinical Research Center for Rheumatology and Allergy, National Hospital Organization Sagamihara National Hospital, Kanagawa, Japan</addr-line></aff><aff id="aff8"><label>8</label><addr-line>Laboratory for Genotyping Development, Center for Genomic Medicine, RIKEN, Kanagawa, Japan</addr-line></aff><aff id="aff9"><label>9</label><addr-line>Laboratory for Medical Informatics, Center for Genomic Medicine, RIKEN, Kanagawa, Japan</addr-line></aff><aff id="aff10"><label>10</label><addr-line>Department of Orthopaedics University of Thessaly, Larissa, Greece</addr-line></aff><aff id="aff11"><label>11</label><addr-line>Institute for Biomedical Research and Technology, Larissa, Greece</addr-line></aff><aff id="aff12"><label>12</label><addr-line>Department of Biology, University of Thessaly Medical School, Larissa, Greece</addr-line></aff><aff id="aff13"><label>13</label><addr-line>Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan</addr-line></aff><aff id="aff14"><label>14</label><addr-line>Center for Genomic Medicine, RIKEN, Kanagawa, Japan</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Agarwal</surname><given-names>Sudha</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1">Ohio State University, United States of America</aff><author-notes><corresp id="cor1">&#x0002a; E-mail: <email>sikegawa@ims.u-tokyo.ac.jp</email></corresp><fn fn-type="con"><p>Wrote the paper: MN SI. Planned and supervised the whole project: SI. Performed the Japanese association study: MN IK TF JD. Managed the European association study: A. Tsezou AG. Helped with statistic analysis: A. Takahashi NK TT. Managed DNA sample and/or clinical information: CR-F JJG-R AS AU NF KNM A. Tsezou AG YN. Oversaw a genotyping of GWAS: MK YN.</p></fn></author-notes><pub-date pub-type="collection"><year>2010</year></pub-date><pub-date pub-type="epub"><day>18</day><month>3</month><year>2010</year></pub-date><volume>5</volume><issue>3</issue><elocation-id>e9723</elocation-id><history><date date-type="received"><day>28</day><month>12</month><year>2009</year></date><date date-type="accepted"><day>26</day><month>2</month><year>2010</year></date></history><permissions><copyright-statement>Nakajima et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</copyright-statement></permissions><abstract><p>Osteoarthritis (OA) is a common disease that has a definite genetic component. Only a few OA susceptibility genes that have definite functional evidence and replication of association have been reported, however. Through a genome-wide association study and a replication using a total of &#x0223c;4,800 Japanese subjects, we identified two single nucleotide polymorphisms (SNPs) (rs7775228 and rs10947262) associated with susceptibility to knee OA. The two SNPs were in a region containing HLA class II/III genes and their association reached genome-wide significance (combined <italic>P</italic>&#x0200a;&#x0003d;&#x0200a;2.43&#x000d7;10<sup>&#x02212;8</sup> for rs7775228 and 6.73&#x000d7;10<sup>&#x02212;8</sup> for rs10947262). Our results suggest that immunologic mechanism is implicated in the etiology of OA.</p></abstract><counts><page-count count="6"/></counts></article-meta></front><body><sec id="s1"><title>Introduction</title><p>We are living in the &#x0201c;Bone and Joint Decade&#x0201d; (<ext-link ext-link-type="uri" xlink:href="http://www.boneandjointdecade.org/">http://www.boneandjointdecade.org/</ext-link>). As the WHO initiative shows, bone and joint diseases are serious problems all over the world, putting us under severe medical, economical and social burden. Osteoarthritis (OA; MIM 165720) is one of the most common diseases among them. OA affects synovial joints of all over the body, mainly knee, hip, hand and spine. OA is characterized by progressive loss of articular cartilage and, often, proliferation of synovium and bone, which lead to pain, loss of joint function and disability. More than tens of millions patients in the world are suffering from this non-lethal, but intractable disease, and the number is relentlessly increasing; however, its etiological picture remains unclear and we have no fundamental treatment for it.</p><p>OA is a polygenic disease. Both environmental and genetic factors contribute to its etiology and pathogenesis <xref ref-type="bibr" rid="pone.0009723-Ikegawa1">&#x0005b;1&#x0005d;</xref>. To understand its genetic factor, identification of its susceptibility gene(s) must be the first step. Many OA susceptibility genes identified by candidate-gene association studies have been reported, but only a few have supporting functional evidence and replication of the results in different populations <xref ref-type="bibr" rid="pone.0009723-Ikegawa1">&#x0005b;1&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0009723-Dai1">&#x0005b;2&#x0005d;</xref>. Large-scale association studies including the genome-wide association study (GWAS) using high-density single nucleotide polymorphisms (SNPs) have been reported by a few groups in Asia and Europe <xref ref-type="bibr" rid="pone.0009723-Mototani1">&#x0005b;3&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0009723-Valdes1">&#x0005b;6&#x0005d;</xref>, but only a gene fulfilled genome-wide significance level <xref ref-type="bibr" rid="pone.0009723-Dai1">&#x0005b;2&#x0005d;</xref>. The genetic basis of OA susceptibility remains largely uncharacterized. To identify OA susceptibility gene(s), we conducted a GWAS for knee OA and identified two SNPs with genome-wide significance level.</p></sec><sec id="s2" sec-type="methods"><title>Methods</title><sec id="s2a"><title>Samples</title><p>Characteristics of each cohort group are shown in <xref ref-type="table" rid="pone-0009723-t001">Table 1</xref>. Case samples of GWAS for the Japanese population were obtained from several medical institutes in Japan, as previously described <xref ref-type="bibr" rid="pone.0009723-Miyamoto1">&#x0005b;5&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0009723-Miyamoto2">&#x0005b;7&#x0005d;</xref>. Knee OA was diagnosed on the basis of clinical and radiographic findings using previously described criteria <xref ref-type="bibr" rid="pone.0009723-Miyamoto1">&#x0005b;5&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0009723-Miyamoto2">&#x0005b;7&#x0005d;</xref>. Rheumatoid arthritis (RA) and polyarthritis associated with autoimmune diseases were excluded, as were secondary OA due to crystal deposition (gout and pseudogout), posttraumatic OA and infection-induced OA. Patients who had clinical and radiographic findings suggestive of skeletal dysplasias, including overt short stature, multiple symmetric involvements of epiphyses and a definitely positive Mendelian family history were also excluded from the study. The control groups consisted of 3,396 individuals that were registered in the Leading Project for Personalized Medicine in the Ministry of Education, Culture, Sports, Science and Technology, Japan as the subjects with diseases unrelated to OA and the volunteers in the Osaka-Midosuji Rotary Club, Osaka, Japan <xref ref-type="bibr" rid="pone.0009723-Nakamura1">&#x0005b;8&#x0005d;</xref>. For replication study, we recruited population-based cohorts from inhabitants of Odai and Minami-ise town (previously Miyagawa village and Nansei town, respectively in the Mie prefecture in Japan) <xref ref-type="bibr" rid="pone.0009723-Kizawa1">&#x0005b;9&#x0005d;</xref>. The Spanish and Greek knee OA and control populations were recruited as described previously from the Hospital Clinico de Santiago, the Departments of Biology and Genetics and of Orthopaedics, University of Thessaly and the Institute of Musculoskeletal Sciences <xref ref-type="bibr" rid="pone.0009723-RodriguezLopez1">&#x0005b;10&#x0005d;</xref>. All the participants provided written informed consent. This research project was approved by the ethical committees at Center for Genomic Medicine (formerly, SNP Research Center), RIKEN and the participating institutions.</p><table-wrap id="pone-0009723-t001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0009723.t001</object-id><label>Table 1</label><caption><title>Basal characteristics of the subjects.</title></caption><alternatives><graphic id="pone-0009723-t001-1" xlink:href="pone.0009723.t001"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td colspan="2" align="left" rowspan="1">Cohort</td><td align="left" rowspan="1" colspan="1">Source</td><td align="left" rowspan="1" colspan="1">Platform</td><td align="left" rowspan="1" colspan="1">Number of samples</td><td align="left" rowspan="1" colspan="1">Nationality</td><td align="left" rowspan="1" colspan="1">Female (&#x00025;)</td><td align="left" rowspan="1" colspan="1">Age (mean &#x0002b;/&#x02212; sd)</td><td align="left" rowspan="1" colspan="1">BMI (mean &#x0002b;/&#x02212; sd)</td><td align="left" rowspan="1" colspan="1">Severity<xref ref-type="table-fn" rid="nt102">a</xref> (&#x00025; severe OA)</td></tr></thead><tbody><tr><td colspan="2" align="left" rowspan="1"><bold>GWAS</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">knee OA</td><td align="left" rowspan="1" colspan="1">RIKEN</td><td align="left" rowspan="1" colspan="1">Illumina HumanHap550</td><td align="left" rowspan="1" colspan="1">899</td><td align="left" rowspan="1" colspan="1">Japanese</td><td align="left" rowspan="1" colspan="1">759 (84.4)</td><td align="left" rowspan="1" colspan="1">71.6&#x0002b;/&#x02212;7.6</td><td align="left" rowspan="1" colspan="1">24.9&#x0002b;/&#x02212;3.6</td><td align="left" rowspan="1" colspan="1">76.5</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">control</td><td align="left" rowspan="1" colspan="1">ORC&#x0002b;BioBank Japan</td><td align="left" rowspan="1" colspan="1">Illumina HumanHap550</td><td align="left" rowspan="1" colspan="1">3,396</td><td align="left" rowspan="1" colspan="1">Japanese</td><td align="left" rowspan="1" colspan="1">1,491 (43.9)</td><td align="left" rowspan="1" colspan="1">52.5&#x0002b;/&#x02212;15.2</td><td align="left" rowspan="1" colspan="1">22.5&#x0002b;/&#x02212;3.7</td><td align="left" rowspan="1" colspan="1">&#x02013;</td></tr><tr><td colspan="2" align="left" rowspan="1"><bold>Replication</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td colspan="2" align="left" rowspan="1">Japanese</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">knee OA</td><td align="left" rowspan="1" colspan="1">RIKEN</td><td align="left" rowspan="1" colspan="1">Invader assay</td><td align="left" rowspan="1" colspan="1">167</td><td align="left" rowspan="1" colspan="1">Japanese</td><td align="left" rowspan="1" colspan="1">124 (74.3)</td><td align="left" rowspan="1" colspan="1">73.8&#x0002b;/&#x02212;6.1</td><td align="left" rowspan="1" colspan="1">24.5&#x0002b;/&#x02212;3.3</td><td align="left" rowspan="1" colspan="1">48.5</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">control</td><td align="left" rowspan="1" colspan="1">RIKEN</td><td align="left" rowspan="1" colspan="1">Invader assay</td><td align="left" rowspan="1" colspan="1">347</td><td align="left" rowspan="1" colspan="1">Japanese</td><td align="left" rowspan="1" colspan="1">223 (64.3)</td><td align="left" rowspan="1" colspan="1">65.9&#x0002b;/&#x02212;8.7</td><td align="left" rowspan="1" colspan="1">22.3&#x0002b;/&#x02212;2.7</td><td align="left" rowspan="1" colspan="1">&#x02013;</td></tr><tr><td colspan="3" align="left" rowspan="1">European Caucasian</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">knee OA</td><td align="left" rowspan="1" colspan="1">Santiago de Compostela</td><td align="left" rowspan="1" colspan="1">SNaPshot</td><td align="left" rowspan="1" colspan="1">243</td><td align="left" rowspan="1" colspan="1">Spanish</td><td align="left" rowspan="1" colspan="1">197 (81.1)</td><td align="left" rowspan="1" colspan="1">68.0&#x0002b;/&#x02212;5.7</td><td align="left" rowspan="1" colspan="1">32.8&#x0002b;/&#x02212;4.8</td><td align="left" rowspan="1" colspan="1">ND<xref ref-type="table-fn" rid="nt103">b</xref></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">control</td><td align="left" rowspan="1" colspan="1">Santiago de Compostela</td><td align="left" rowspan="1" colspan="1">SNaPshot</td><td align="left" rowspan="1" colspan="1">426</td><td align="left" rowspan="1" colspan="1">Spanish</td><td align="left" rowspan="1" colspan="1">165 (38.7)</td><td align="left" rowspan="1" colspan="1">68.4&#x0002b;/&#x02212;9.1</td><td align="left" rowspan="1" colspan="1">28.3&#x0002b;/&#x02212;3.8</td><td align="left" rowspan="1" colspan="1">&#x02013;</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">knee OA</td><td align="left" rowspan="1" colspan="1">University of Thessaly</td><td align="left" rowspan="1" colspan="1">SNaPshot</td><td align="left" rowspan="1" colspan="1">570</td><td align="left" rowspan="1" colspan="1">Greek</td><td align="left" rowspan="1" colspan="1">468 (82.1)</td><td align="left" rowspan="1" colspan="1">65.8&#x0002b;/&#x02212;8.7</td><td align="left" rowspan="1" colspan="1">29.1&#x0002b;/&#x02212;3.3</td><td align="left" rowspan="1" colspan="1">77.1</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">control</td><td align="left" rowspan="1" colspan="1">University of Thessaly</td><td align="left" rowspan="1" colspan="1">SNaPshot</td><td align="left" rowspan="1" colspan="1">645</td><td align="left" rowspan="1" colspan="1">Greek</td><td align="left" rowspan="1" colspan="1">417 (64.6)</td><td align="left" rowspan="1" colspan="1">59.5&#x0002b;/&#x02212;11.6</td><td align="left" rowspan="1" colspan="1">25.4&#x0002b;/&#x02212;3.7</td><td align="left" rowspan="1" colspan="1">&#x02013;</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt101"><label/><p>OA: osteoarthritis, ORC: Osaka-Midosuji Rotary Club.</p></fn><fn id="nt102"><label>a</label><p>Kellegren-Laurence grade &#x02265;3 was considered as severe OA.</p></fn><fn id="nt103"><label>b</label><p>All cases underwent TKR (total knee replacement) surgery.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s2b"><title>SNP genotyping</title><p>For the GWAS, we genotyped 906 patients with OA and 3,396 controls using Illumina HumanHap550v3 Genotyping BeadChip. After excluding seven cases with call rate of &#x0003c;0.98, we applied SNP QC (call rate of &#x02265;0.99 in both cases and controls and <italic>P</italic> value of Hardy-Weinberg equilibrium test of &#x02265;1.0&#x000d7;10<sup>&#x02212;6</sup> in controls). Finally, 459,393 SNPs on autosomal chromosomes passed the QC filters and were further analyzed. Among the SNPs analyzed in the GWAS, we selected top 15 SNPs showing the smallest <italic>P</italic> values (<italic>P</italic>&#x0003c;1&#x000d7;10<sup>&#x02212;5</sup>) for the replication study using an independent 514 Japanese subjects from a resident cohort. SNPs with minor allele frequency of &#x02264;0.1 in both case and control samples were excluded from the further analysis. In the replication analysis, we genotyped SNPs using the multiplex PCR-based invader assay (Third Wave Technologies) or by direct sequencing of PCR products using ABI 3700 DNA analyzers (Applied Biosystems), or by SNaPshot Multiplex System (Applied Biosystems) according to manufacturers' protocols.</p></sec><sec id="s2c"><title>Statistical analysis</title><p>In the GWAS and replication analyses, we applied Fisher's exact test to two-by-two contingency table in three genetic models: an allele frequency model, a dominant-effect model, and a recessive-effect model. We conducted the meta-analysis using the Mantel-Haenszel method. We examined heterogeneity among studies by using the Breslow-Day test. Significance levels after the Bonferroni correction for multiple testing were <italic>P</italic>&#x0200a;&#x0003d;&#x0200a;1.09&#x000d7;10<sup>&#x02212;7</sup> (0.05/459,393). Age, gender- and BMI-adjusted odds ratios were obtained by logistic regression analysis <xref ref-type="bibr" rid="pone.0009723-Andrieu1">&#x0005b;11&#x0005d;</xref>. Odds ratios and confidence intervals were calculated using the risk allele as a reference. We analyzed the haplotype association using Haploview software <xref ref-type="bibr" rid="pone.0009723-Barrett1">&#x0005b;12&#x0005d;</xref>. We conducted a principal component analysis to detect population stratification <xref ref-type="bibr" rid="pone.0009723-Price1">&#x0005b;13&#x0005d;</xref>.</p></sec><sec id="s2d"><title>Software</title><p>For general statistical analysis, we used R statistical environment version 2.6.1 or Microsoft Excel. Drawing the LD map, estimation of haplotype frequencies and analysis of haplotype association were performed by Haploview software.</p></sec></sec><sec id="s3"><title>Results</title><p>To identify genetic variants that determine OA susceptibility, we conducted a GWAS in Japanese knee OA. We examined 906 individuals with knee OA and 3,396 control individuals (<xref ref-type="table" rid="pone-0009723-t001">Table 1</xref>) using Illumina HumanHap550v3 Genotyping BeadChip. After confirming the data quality, we compared the results of 459,393 SNPs between cases and controls by Fisher's exact test for three genetic models: allelic, dominant or recessive (<xref ref-type="fig" rid="pone-0009723-g001">Figure 1</xref>). Fifteen SNPs selected for the replication study that had the smallest <italic>P</italic> values (minimum <italic>P</italic>&#x0003c;1&#x000d7;10<sup>&#x02212;5</sup>) were next genotyped in an independent set of 167 Japanese knee OA individuals and 347 Japanese controls from a resident cohort study. Through these studies, only two SNPs, rs7775228 (combined <italic>P</italic>&#x0200a;&#x0003d;&#x0200a;2.43&#x000d7;10<sup>&#x02212;8</sup>; OR&#x0200a;&#x0003d;&#x0200a;1.34; 95&#x00025; CI&#x0200a;&#x0003d;&#x0200a;1.21&#x02013;1.49) and rs10947262 (combined <italic>P</italic>&#x0200a;&#x0003d;&#x0200a;6.73&#x000d7;10<sup>&#x02212;8</sup>; OR&#x0200a;&#x0003d;&#x0200a;1.32; 95&#x00025; CI&#x0200a;&#x0003d;&#x0200a;1.19&#x02013;1.46) were significant even after the Bonferroni correction for multiple testing (<italic>P</italic>&#x0200a;&#x0003d;&#x0200a;1.09&#x000d7;10<sup>&#x02212;7</sup>) (<xref ref-type="table" rid="pone-0009723-t002">Table 2</xref>). The two SNPs showing significant associations are located within a 340-kb region within the HLA locus, including <italic>BTNL2</italic>, <italic>HLA-DRA</italic>, <italic>HLA-DRB5</italic>, <italic>HLA-DRB1</italic>, <italic>HLA-DQA1</italic> and <italic>HLA-DQB1</italic> (<xref ref-type="fig" rid="pone-0009723-g002">Figure 2</xref>). Although the HLA region is known to show extensive linkage disequilibrium (LD) spanning over 7 Mb, only SNPs in the 340-kb region showed strong associations with OA (<xref ref-type="fig" rid="pone-0009723-g002">Figure 2</xref>), and SNPs outside of this region did not have significant association.</p><fig id="pone-0009723-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0009723.g001</object-id><label>Figure 1</label><caption><title>Results of a genome-wide association study (&#x02013;log<sub>10</sub><italic>P</italic> value plot).</title><p>Each <italic>P</italic> value is the minimum of Fisher's exact tests for three models: dominant, recessive and allele frequency model.</p></caption><graphic xlink:href="pone.0009723.g001"/></fig><fig id="pone-0009723-g002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0009723.g002</object-id><label>Figure 2</label><caption><title>Case-control association analysis and linkage disequilibrium (LD) map of the HLA class II/III region of chromosome 6.</title><p>(A) The LD map based on <italic>D</italic>' was drawn using HapMap data release 24 for the JPT population. (B) Genomic structure within the extended HLA-II/III region. (C) Results of GWAS for osteoarthritis in Japanese population. The log<sub>10</sub>-transformed <italic>P</italic> values are plotted on the <italic>y</italic> axis.</p></caption><graphic xlink:href="pone.0009723.g002"/></fig><table-wrap id="pone-0009723-t002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0009723.t002</object-id><label>Table 2</label><caption><title>Association of rs7775228 and rs10947262 with knee osteoarthritis.</title></caption><alternatives><graphic id="pone-0009723-t002-2" xlink:href="pone.0009723.t002"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1">SNP (Nearest gene)</td><td align="left" rowspan="1" colspan="1">Allele</td><td align="left" rowspan="1" colspan="1">Population</td><td colspan="2" align="left" rowspan="1">Minor allele Frequency</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Case</td><td align="left" rowspan="1" colspan="1">Control</td><td align="left" rowspan="1" colspan="1">OR (95&#x00025; CI)<xref ref-type="table-fn" rid="nt105">a</xref></td><td align="left" rowspan="1" colspan="1"><italic>P</italic><xref ref-type="table-fn" rid="nt106">b</xref></td><td align="left" rowspan="1" colspan="1"><italic>P</italic><sub>het</sub><xref ref-type="table-fn" rid="nt107">c</xref></td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">rs7775228</td><td align="left" rowspan="1" colspan="1">C/T</td><td align="left" rowspan="1" colspan="1">Japanese</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">(<italic>HLA-DQB1</italic>)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">GWAS</td><td align="left" rowspan="1" colspan="1">0.318</td><td align="left" rowspan="1" colspan="1">0.379</td><td align="left" rowspan="1" colspan="1">1.31 (1.18&#x02013;1.47)</td><td align="left" rowspan="1" colspan="1">1.38 E-06</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Replication</td><td align="left" rowspan="1" colspan="1">0.290</td><td align="left" rowspan="1" colspan="1">0.385</td><td align="left" rowspan="1" colspan="1">1.53 (1.15&#x02013;2.02)</td><td align="left" rowspan="1" colspan="1">3.07 E-03</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Combined<xref ref-type="table-fn" rid="nt108">d</xref></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">1.34 (1.21&#x02013;1.49)</td><td align="left" rowspan="1" colspan="1">2.43 E-08</td><td align="left" rowspan="1" colspan="1">0.33</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">European Caucasian</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Spanish</td><td align="left" rowspan="1" colspan="1">0.194</td><td align="left" rowspan="1" colspan="1">0.209</td><td align="left" rowspan="1" colspan="1">1.10 (0.83&#x02013;1.45)</td><td align="left" rowspan="1" colspan="1">0.521</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Greek</td><td align="left" rowspan="1" colspan="1">0.094</td><td align="left" rowspan="1" colspan="1">0.075</td><td align="left" rowspan="1" colspan="1">0.78 (0.58&#x02013;1.03)</td><td align="left" rowspan="1" colspan="1">0.084</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">European combined<xref ref-type="table-fn" rid="nt109">e</xref></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">0.93 (0.76&#x02013;1.13)</td><td align="left" rowspan="1" colspan="1">0.178</td><td align="left" rowspan="1" colspan="1">0.09</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">All combined<xref ref-type="table-fn" rid="nt110">f</xref></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">0.003</td></tr><tr><td align="left" rowspan="1" colspan="1">rs10947262</td><td align="left" rowspan="1" colspan="1">C/T</td><td align="left" rowspan="1" colspan="1">Japanese</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">(<italic>BTNL2</italic>)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">GWAS</td><td align="left" rowspan="1" colspan="1">0.358</td><td align="left" rowspan="1" colspan="1">0.419</td><td align="left" rowspan="1" colspan="1">1.30 (1.16&#x02013;1.44)</td><td align="left" rowspan="1" colspan="1">2.45 E-06</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Replication</td><td align="left" rowspan="1" colspan="1">0.332</td><td align="left" rowspan="1" colspan="1">0.422</td><td align="left" rowspan="1" colspan="1">1.47 (1.12&#x02013;1.93)</td><td align="left" rowspan="1" colspan="1">5.74 E-03</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Combined<xref ref-type="table-fn" rid="nt108">d</xref></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">1.32 (1.19&#x02013;1.46)</td><td align="left" rowspan="1" colspan="1">6.73 E-08</td><td align="left" rowspan="1" colspan="1">0.40</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">European Caucasian</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Spanish</td><td align="left" rowspan="1" colspan="1">0.122</td><td align="left" rowspan="1" colspan="1">0.136</td><td align="left" rowspan="1" colspan="1">1.13 (0.81&#x02013;1.59)</td><td align="left" rowspan="1" colspan="1">0.465</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Greek</td><td align="left" rowspan="1" colspan="1">0.068</td><td align="left" rowspan="1" colspan="1">0.094</td><td align="left" rowspan="1" colspan="1">1.43 (1.06&#x02013;1.92)</td><td align="left" rowspan="1" colspan="1">0.019</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">European combined<xref ref-type="table-fn" rid="nt109">e</xref></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">1.29 (1.03&#x02013;1.61)</td><td align="left" rowspan="1" colspan="1">0.025</td><td align="left" rowspan="1" colspan="1">0.32</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">All combined<xref ref-type="table-fn" rid="nt110">f</xref></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">1.31 (1.20&#x02013;1.44)</td><td align="left" rowspan="1" colspan="1">5.10 E-09</td><td align="left" rowspan="1" colspan="1">0.63</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt104"><label/><p>Odds ratios (ORs) and <italic>P</italic> values for the independence test were calculated by the Mantel-Haenszel method.</p></fn><fn id="nt105"><label>a</label><p>OR of the risk allele from the two-by-two allele frequency table.</p></fn><fn id="nt106"><label>b</label><p>P values of the Pearson's &#x003c7;<sup>2</sup> test for the allele model.</p></fn><fn id="nt107"><label>c</label><p>Results of the Breslow-Day test.</p></fn><fn id="nt108"><label>d</label><p>Meta-analysis of Japanese studies.</p></fn><fn id="nt109"><label>e</label><p>Meta-analysis of European studies.</p></fn><fn id="nt110"><label>f</label><p>Meta-analysis of all studies.</p></fn></table-wrap-foot></table-wrap><p>Application of the Cochrane-Armitage test to all the tested SNPs indicated that the genetic inflation factor lambda was 1.08 for GWAS (<xref ref-type="fig" rid="pone-0009723-g003">Figure 3</xref>), implying a low possibility of false positive associations due to population stratification. We also carried out age, gender- and BMI-adjusted analysis using a logistic regression model, and confirmed similar association after adjustment (data not shown). The principal component analysis <xref ref-type="bibr" rid="pone.0009723-Price1">&#x0005b;13&#x0005d;</xref> revealed that there was no evidence for population stratification between the two control groups used for the GWAS (<xref ref-type="supplementary-material" rid="pone.0009723.s001">Figure S1</xref>).</p><fig id="pone-0009723-g003" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0009723.g003</object-id><label>Figure 3</label><caption><title>GWAS of knee osteoarthritis.</title><p>Q-Q plot with Cochrane-Armitage trend <italic>P</italic> in the GWAS<bold>.</bold> Horizontal and vertical lines represent expected <italic>P</italic> values under a null distribution and observed <italic>P</italic> values, respectively. The genetic inflation factor lambda is 1.08.</p></caption><graphic xlink:href="pone.0009723.g003"/></fig><p>To check the association of rs7775228 and rs10947262 in different ethnic populations, we examined the association of the SNPs with knee OA in two European Caucasian populations from Greece and Spain. We genotyped a total of 813 OA and 1,071 control subjects (<xref ref-type="table" rid="pone-0009723-t001">Table 1</xref>). We conducted the meta-analysis using the Mantel-Haenszel method. The combined European results for rs7775228 were not significant with OR (95&#x00025;CI) of 0.93 (0.76&#x02013;1.13) (<xref ref-type="table" rid="pone-0009723-t002">Table 2</xref>), while those for rs10947262 were supportive with OR (95&#x00025;CI) of 1.29 (1.03&#x02013;1.61). rs10947262 showed replication in the Greek population and the same trend in the Spanish population (<xref ref-type="table" rid="pone-0009723-t002">Table 2</xref>). A meta-analysis of the Japanese and two European studies gave more significant association (combined <italic>P</italic>&#x0200a;&#x0003d;&#x0200a;5.10&#x000d7;10<sup>&#x02212;9</sup>).</p><p>We estimated the pairwise LD indexes (<italic>D</italic>' and <italic>r<sup>2</sup></italic>) between rs7775228 and rs10947262 using the genotype data of Japanese populations (GWAS and the replication study), and found that they were in strong LD with each other (<italic>D</italic>'&#x0200a;&#x0003d;&#x0200a;0.82, <italic>r<sup>2</sup></italic>&#x0200a;&#x0003d;&#x0200a;0.56). They formed two frequent haplotypes (Haplotype I and II; <xref ref-type="table" rid="pone-0009723-t003">Table 3</xref>) accounting for about 90&#x00025; of all observed chromosomes. The haplotypes were also significantly associated with knee OA; Haplotype I, the most frequent haplotype was a risk haplotype (<italic>P</italic>&#x0200a;&#x0003d;&#x0200a;1.48&#x000d7;10<sup>&#x02212;8</sup>; OR&#x0200a;&#x0003d;&#x0200a;1.33; 95&#x00025; CI&#x0200a;&#x0003d;&#x0200a;1.20&#x02013;1.46).</p><table-wrap id="pone-0009723-t003" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0009723.t003</object-id><label>Table 3</label><caption><title>Haplotype association analysis for knee osteoarthritis susceptibility SNPs, rs7775228 and rs10947262.</title></caption><alternatives><graphic id="pone-0009723-t003-3" xlink:href="pone.0009723.t003"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td colspan="2" align="left" rowspan="1">Frequency</td><td colspan="2" align="left" rowspan="1">Haplotype effect<xref ref-type="table-fn" rid="nt113">b</xref></td></tr><tr><td colspan="2" align="left" rowspan="1">Haplotype<xref ref-type="table-fn" rid="nt112">a</xref></td><td align="left" rowspan="1" colspan="1">Case</td><td align="left" rowspan="1" colspan="1">Control</td><td align="left" rowspan="1" colspan="1">OR (95&#x00025; CI)</td><td align="left" rowspan="1" colspan="1">P value</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">I</td><td align="left" rowspan="1" colspan="1">TC</td><td align="left" rowspan="1" colspan="1">0.610</td><td align="left" rowspan="1" colspan="1">0.541</td><td align="left" rowspan="1" colspan="1">1.33 (1.20&#x02013;1.46)</td><td align="left" rowspan="1" colspan="1">1.48 E-8</td></tr><tr><td align="left" rowspan="1" colspan="1">II</td><td align="left" rowspan="1" colspan="1">CT</td><td align="left" rowspan="1" colspan="1">0.277</td><td align="left" rowspan="1" colspan="1">0.340</td><td align="left" rowspan="1" colspan="1">0.74 (0.67&#x02013;0.83)</td><td align="left" rowspan="1" colspan="1">5.07 E-8</td></tr><tr><td align="left" rowspan="1" colspan="1">III</td><td align="left" rowspan="1" colspan="1">CC</td><td align="left" rowspan="1" colspan="1">0.077</td><td align="left" rowspan="1" colspan="1">0.080</td><td align="left" rowspan="1" colspan="1">0.96 (0.80&#x02013;1.15)</td><td align="left" rowspan="1" colspan="1">0.653</td></tr><tr><td align="left" rowspan="1" colspan="1">IV</td><td align="left" rowspan="1" colspan="1">TT</td><td align="left" rowspan="1" colspan="1">0.037</td><td align="left" rowspan="1" colspan="1">0.040</td><td align="left" rowspan="1" colspan="1">0.91 (0.71&#x02013;1.18)</td><td align="left" rowspan="1" colspan="1">0.475</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt111"><label/><p>OR: odds ratio, CI: confidence interval.</p></fn><fn id="nt112"><label>a</label><p>Alleles of rs7775228 (C/T) and rs10947262 (C/T) with this order.</p></fn><fn id="nt113"><label>b</label><p>A haplotype vs. all others.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s4"><title>Discussion</title><p>We performed a GWAS followed by a replication in an independent population using a total of &#x0223c;4,800 Japanese subjects, and identified two SNPs (rs7775228 and rs10947262) in the HLA class II/III locus associated with susceptibility to knee OA. To our knowledge, this study represents the first GWAS of OA with extensive coverage (&#x0223c;550,000 markers) and definite genome-wide significance even after Bonferroni's correction, which is very conservative. There were no effects of population stratification and confounding factors. Since two groups of controls were used in the GWAS, we evaluated the possibility of genetic heterogeneity between the two groups by a principal component analysis and found it unlikely (<xref ref-type="supplementary-material" rid="pone.0009723.s001">Figure S1</xref>). Although there was large age difference between the case and control groups of GWAS (<xref ref-type="table" rid="pone-0009723-t001">Table 1</xref>), significant association was observed after the age adjustment.</p><p>In the NCBI genome database, rs7775228 and rs10947262 located between upstream region of <italic>HLA-DQA2</italic> and <italic>HLA-DQB1</italic>, and within the intron 1 of <italic>BTNL2</italic>, respectively (<xref ref-type="fig" rid="pone-0009723-g002">Figure 2</xref>). <italic>HLA-DQA2</italic> and <italic>HLA-DQB1</italic> encode HLA-DQ &#x003b1; and &#x003b2; chains, which belong to the HLA class II molecules. HLA class II molecules are expressed in antigen presenting cells (B lymphocytes, dendritic cells and macrophages) and play a central role in the immune system by presenting peptides derived from extracellular proteins <xref ref-type="bibr" rid="pone.0009723-Alberts1">&#x0005b;14&#x0005d;</xref>. The HLA-DQA<italic>2</italic> protein is expressed, but at a very low level in comparison with the HLA-DQA1 protein <xref ref-type="bibr" rid="pone.0009723-Yu1">&#x0005b;15&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0009723-Rudy1">&#x0005b;16&#x0005d;</xref>. Moreover, the HLA-DQA2 &#x003b1; chain does not dimerize with class II &#x003b2; chains <xref ref-type="bibr" rid="pone.0009723-Rudy1">&#x0005b;16&#x0005d;</xref>. <italic>BTNL2</italic> encodes butyrophilin-like 2, a member of butyrophilin family that shares sequence homology with the B7 co-stimulatory molecules. BTNL2 regulates T-cell activation through unknown receptor, distinct from CD28 and CTLA-4 <xref ref-type="bibr" rid="pone.0009723-Arnett1">&#x0005b;17&#x0005d;</xref>. In Japanese population, the haplotype association was more significant than those of respective SNPs (<xref ref-type="table" rid="pone-0009723-t002">Tables 2</xref> and <xref ref-type="table" rid="pone-0009723-t003">3</xref>). Therefore, there may be hidden SNP(s) with a lower <italic>P</italic> value than rs7775228 and rs10947262, or the haplotype may be implicated in the OA susceptibility. An association of sarcoidosis with rs2076530, a coding SNP on exon 5 of the <italic>BTNL2</italic> gene has been reported <xref ref-type="bibr" rid="pone.0009723-Valentonyte1">&#x0005b;18&#x0005d;</xref>, but the SNP was not in LD with rs10947262 (<italic>D</italic>'&#x0200a;&#x0003d;&#x0200a;0.11, <italic>r<sup>2</sup></italic>&#x0200a;&#x0003d;&#x0200a;0).</p><p>The 340-kb region of HLA locus, where the two SNPs are located also includes <italic>HLA-DRA</italic>, <italic>HLA-DRB1</italic>, <italic>HLA-DRB3</italic>, <italic>HLA-DRB4</italic>, <italic>HLA-DRB5</italic> and <italic>HLA-DQA1</italic>. <italic>HLA-DRA</italic>, <italic>HLA-DRB1/3/4/5</italic> and <italic>HLA-DQA1</italic> encode HLA-DR &#x003b1;, &#x003b2; and HLA-DQ &#x003b1; chains, which could also belong to the HLA class II molecules. <italic>HLA-DRB1</italic> is present in all individuals. Allelic variants of <italic>HLA-DRB1</italic> are linked with either none or one of the genes <italic>HLA-DRB3</italic>, <italic>HLA-DRB4</italic> and <italic>HLA-DRB5</italic><xref ref-type="bibr" rid="pone.0009723-Clayton1">&#x0005b;19&#x0005d;</xref>. Among these genes, <italic>HLA-DRB1</italic> is strongly associated with RA. Some subtypes of HLA-DRB1 alleles, such as &#x0002a;0101, &#x0002a;0401, and &#x0002a;0405, is associated with RA <xref ref-type="bibr" rid="pone.0009723-Evans1">&#x0005b;20&#x0005d;</xref>, but not with generalized OA <xref ref-type="bibr" rid="pone.0009723-Wakitani1">&#x0005b;21&#x0005d;</xref>.</p><p>Although OA has generally been considered a non-inflammatory disease, accumulating evidences suggest that this is not the case. Inflammation involving activated T cells in the synovial membrane of OA patients is well documented <xref ref-type="bibr" rid="pone.0009723-Sakkas1">&#x0005b;22&#x0005d;</xref>. Recently, we identified a genetic variant of <italic>EDG2</italic> gene encoding lysophosphatidic acid receptor associated with knee OA <xref ref-type="bibr" rid="pone.0009723-Mototani2">&#x0005b;23&#x0005d;</xref>. A GWAS has identified a genetic variant of the <italic>PTGS2</italic> gene encoding cyclooxygenase-2 involved in risk for knee OA <xref ref-type="bibr" rid="pone.0009723-Valdes1">&#x0005b;6&#x0005d;</xref>. These genetic associations of genes such as <italic>EDG2</italic> and <italic>PTGS2</italic> underscore the potential role of inflammatory pathways in the pathogenesis of knee OA.</p><p>Several studies have suggested associations of OA with HLA class I and class II alleles. Study on generalized OA revealed association with HLA A1-B8 in Caucasian <xref ref-type="bibr" rid="pone.0009723-Pattrick1">&#x0005b;24&#x0005d;</xref> and with HLA-Cw4 in Japanese <xref ref-type="bibr" rid="pone.0009723-Wakitani1">&#x0005b;21&#x0005d;</xref>. An association of the HLA-DRB1&#x0002a;02 alleles with knee and hip OA was identified in a cohort of 106 patients <xref ref-type="bibr" rid="pone.0009723-Moos1">&#x0005b;25&#x0005d;</xref>. Interestingly, chondrocyte, which are normally HLA-DP, DQ and DR-negative, become positive for them in OA <xref ref-type="bibr" rid="pone.0009723-Lance1">&#x0005b;26&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0009723-Sakata1">&#x0005b;27&#x0005d;</xref>, suggesting their function as antigen-presenting cells. Cartilage fragments are mechanically shaved from the joint surface and frequently found in the synovial membrane of OA patients <xref ref-type="bibr" rid="pone.0009723-Revell1">&#x0005b;28&#x0005d;</xref>. So, physical interaction between chondrocytes and T cells is conceivable. Peripheral blood T cells from OA patients show significantly higher proliferative responses to autologous chondrocytes <xref ref-type="bibr" rid="pone.0009723-Sakata1">&#x0005b;27&#x0005d;</xref>. Our results further support the concept that OA is an immunologic disorder.</p></sec><sec sec-type="supplementary-material" id="s5"><title>Supporting Information</title><supplementary-material content-type="local-data" id="pone.0009723.s001"><label>Figure S1</label><caption><p>Principal component analysis of GWAS samples. Samples in the GWAS and in HapMap database are analyzed by a program of Smartpca <xref ref-type="bibr" rid="pone.0009723-Barrett1">&#x0005b;12&#x0005d;</xref>, and plotted for the first (X axis) and the second (Y axis) principal component (PC), respectively.</p><p>(0.16 MB TIF)</p></caption><media xlink:href="pone.0009723.s001.tif" mimetype="image" mime-subtype="tiff"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><p>We thank all participating patients, doctors and staffs of collaborating institutes. We also thank Ms. Yoshie Takanashi, Carmen Pena-Pena and technical staffs of Laboratories for Genotyping Development and for Bone and Joint Diseases of CGM, RIKEN, and Laboratorio Investigacion 10 and Rheumatology Unit, Hospital Clinico Universitario de Santiago for genotyping.</p></ack><ref-list><title>References</title><ref id="pone.0009723-Ikegawa1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ikegawa</surname><given-names>S</given-names></name></person-group><year>2007</year><article-title>New gene associations in osteoarthritis: what do they provide, and where are we going?</article-title><source>Curr Opin Rheumatol</source><volume>19</volume><fpage>429</fpage><lpage>434</lpage><pub-id pub-id-type="pmid">17762607</pub-id></mixed-citation></ref><ref id="pone.0009723-Dai1"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dai</surname><given-names>J</given-names></name><name><surname>Ikegawa</surname><given-names>S</given-names></name></person-group><year>2010</year><article-title>Recent advances in association studies of osteoarthritis susceptibility genes.</article-title><source>J Hum Genet</source><volume>55</volume><fpage>77</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">20075947</pub-id></mixed-citation></ref><ref id="pone.0009723-Mototani1"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mototani</surname><given-names>H</given-names></name><name><surname>Mabuchi</surname><given-names>A</given-names></name><name><surname>Saito</surname><given-names>S</given-names></name><name><surname>Fujioka</surname><given-names>M</given-names></name><name><surname>Iida</surname><given-names>A</given-names></name><etal/></person-group><year>2005</year><article-title>A functional single nucleotide polymorphism in the core promoter region of CALM1 is associated with hip osteoarthritis in Japanese.</article-title><source>Hum Mol Genet</source><volume>14</volume><fpage>1009</fpage><lpage>1017</lpage><pub-id pub-id-type="pmid">15746150</pub-id></mixed-citation></ref><ref id="pone.0009723-Spector1"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spector</surname><given-names>TD</given-names></name><name><surname>Reneland</surname><given-names>RH</given-names></name><name><surname>Mah</surname><given-names>S</given-names></name><name><surname>Valdes</surname><given-names>AM</given-names></name><name><surname>Hart</surname><given-names>DJ</given-names></name><etal/></person-group><year>2006</year><article-title>Association between a variation in LRCH1 and knee osteoarthritis: a genome-wide single-nucleotide polymorphism association study using DNA pooling.</article-title><source>Arthritis Rheum</source><volume>54</volume><fpage>524</fpage><lpage>532</lpage><pub-id pub-id-type="pmid">16447229</pub-id></mixed-citation></ref><ref id="pone.0009723-Miyamoto1"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyamoto</surname><given-names>Y</given-names></name><name><surname>Shi</surname><given-names>D</given-names></name><name><surname>Nakajima</surname><given-names>M</given-names></name><name><surname>Ozaki</surname><given-names>K</given-names></name><name><surname>Sudo</surname><given-names>A</given-names></name><etal/></person-group><year>2008</year><article-title>Common variants in DVWA on chromosome 3p24.3 are associated with susceptibility to knee osteoarthritis.</article-title><source>Nat Genet</source><volume>40</volume><fpage>994</fpage><lpage>998</lpage><pub-id pub-id-type="pmid">18622395</pub-id></mixed-citation></ref><ref id="pone.0009723-Valdes1"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Valdes</surname><given-names>AM</given-names></name><name><surname>Loughlin</surname><given-names>J</given-names></name><name><surname>Timms</surname><given-names>KM</given-names></name><name><surname>van Meurs</surname><given-names>JJ</given-names></name><name><surname>Southam</surname><given-names>L</given-names></name><etal/></person-group><year>2008</year><article-title>Genome-wide association scan identifies a prostaglandin-endoperoxide synthase 2 variant involved in risk of knee osteoarthritis.</article-title><source>Am J Hum Genet</source><volume>82</volume><fpage>1231</fpage><lpage>1240</lpage><pub-id pub-id-type="pmid">18471798</pub-id></mixed-citation></ref><ref id="pone.0009723-Miyamoto2"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyamoto</surname><given-names>Y</given-names></name><name><surname>Mabuchi</surname><given-names>A</given-names></name><name><surname>Shi</surname><given-names>D</given-names></name><name><surname>Kubo</surname><given-names>T</given-names></name><name><surname>Takatori</surname><given-names>Y</given-names></name><etal/></person-group><year>2007</year><article-title>A functional polymorphism in the 5' UTR of GDF5 is associated with susceptibility to osteoarthritis.</article-title><source>Nat Genet</source><volume>39</volume><fpage>529</fpage><lpage>533</lpage><pub-id pub-id-type="pmid">17384641</pub-id></mixed-citation></ref><ref id="pone.0009723-Nakamura1"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakamura</surname><given-names>Y</given-names></name></person-group><year>2007</year><article-title>The BioBank Japan Project.</article-title><source>Clin Adv Hematol Oncol</source><volume>5</volume><fpage>696</fpage><lpage>697</lpage><pub-id pub-id-type="pmid">17982410</pub-id></mixed-citation></ref><ref id="pone.0009723-Kizawa1"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kizawa</surname><given-names>H</given-names></name><name><surname>Kou</surname><given-names>I</given-names></name><name><surname>Iida</surname><given-names>A</given-names></name><name><surname>Sudo</surname><given-names>A</given-names></name><name><surname>Miyamoto</surname><given-names>Y</given-names></name><etal/></person-group><year>2005</year><article-title>An aspartic acid repeat polymorphism in asporin inhibits chondrogenesis and increases susceptibility to osteoarthritis.</article-title><source>Nat Genet</source><volume>37</volume><fpage>138</fpage><lpage>144</lpage><pub-id pub-id-type="pmid">15640800</pub-id></mixed-citation></ref><ref id="pone.0009723-RodriguezLopez1"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodriguez-Lopez</surname><given-names>J</given-names></name><name><surname>Pombo-Suarez</surname><given-names>M</given-names></name><name><surname>Loughlin</surname><given-names>J</given-names></name><name><surname>Tsezou</surname><given-names>A</given-names></name><name><surname>Blanco</surname><given-names>FJ</given-names></name><etal/></person-group><year>2009</year><article-title>Association of a nsSNP in ADAMTS14 to some osteoarthritis phenotypes.</article-title><source>Osteoarthritis Cartilage</source><volume>17</volume><fpage>321</fpage><lpage>327</lpage><pub-id pub-id-type="pmid">18790654</pub-id></mixed-citation></ref><ref id="pone.0009723-Andrieu1"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andrieu</surname><given-names>N</given-names></name><name><surname>Goldstein</surname><given-names>AM</given-names></name></person-group><year>1998</year><article-title>Epidemiologic and genetic approaches in the study of gene-environment interaction: an overview of available methods.</article-title><source>Epidemiol Rev</source><volume>20</volume><fpage>137</fpage><lpage>147</lpage><pub-id pub-id-type="pmid">9919434</pub-id></mixed-citation></ref><ref id="pone.0009723-Barrett1"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barrett</surname><given-names>JC</given-names></name><name><surname>Fry</surname><given-names>B</given-names></name><name><surname>Maller</surname><given-names>J</given-names></name><name><surname>Daly</surname><given-names>MJ</given-names></name></person-group><year>2005</year><article-title>Haploview: analysis and visualization of LD and haplotype maps.</article-title><source>Bioinformatics</source><volume>21</volume><fpage>263</fpage><lpage>265</lpage><pub-id pub-id-type="pmid">15297300</pub-id></mixed-citation></ref><ref id="pone.0009723-Price1"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Price</surname><given-names>AL</given-names></name><name><surname>Patterson</surname><given-names>NJ</given-names></name><name><surname>Plenge</surname><given-names>RM</given-names></name><name><surname>Weinblatt</surname><given-names>ME</given-names></name><name><surname>Shadick</surname><given-names>NA</given-names></name><etal/></person-group><year>2006</year><article-title>Principal components analysis corrects for stratification in genome-wide association studies.</article-title><source>Nat Genet</source><volume>38</volume><fpage>904</fpage><lpage>909</lpage><pub-id pub-id-type="pmid">16862161</pub-id></mixed-citation></ref><ref id="pone.0009723-Alberts1"><label>14</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Alberts</surname><given-names>B</given-names></name><name><surname>Johnson</surname><given-names>A</given-names></name><name><surname>Lewis</surname><given-names>J</given-names></name><name><surname>Raff</surname><given-names>M</given-names></name><name><surname>Roberts</surname><given-names>K</given-names></name><etal/></person-group><year>2007</year><article-title>Molecular biology of the cell - Fifth edition.</article-title><publisher-loc>New York</publisher-loc><publisher-name>Garland Science</publisher-name><fpage>1577</fpage><lpage>1579</lpage></mixed-citation></ref><ref id="pone.0009723-Yu1"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>LP</given-names></name><name><surname>Sheehy</surname><given-names>MJ</given-names></name></person-group><year>1991</year><article-title>The cryptic HLA-DQA2 (&#x0201c;DX alpha&#x0201d;) gene is expressed in human B cell lines.</article-title><source>J Immunol</source><volume>147</volume><fpage>4393</fpage><lpage>4397</lpage><pub-id pub-id-type="pmid">1753107</pub-id></mixed-citation></ref><ref id="pone.0009723-Rudy1"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rudy</surname><given-names>GB</given-names></name><name><surname>Lew</surname><given-names>AM</given-names></name></person-group><year>1997</year><article-title>The nonpolymorphic MHC class II isotype, HLA-DQA2, is expressed on the surface of B lymphoblastoid cells.</article-title><source>J Immunol</source><volume>158</volume><fpage>2116</fpage><lpage>2125</lpage><pub-id pub-id-type="pmid">9036956</pub-id></mixed-citation></ref><ref id="pone.0009723-Arnett1"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arnett</surname><given-names>HA</given-names></name><name><surname>Escobar</surname><given-names>SS</given-names></name><name><surname>Gonzalez-Suarez</surname><given-names>E</given-names></name><name><surname>Budelsky</surname><given-names>AL</given-names></name><name><surname>Steffen</surname><given-names>LA</given-names></name><etal/></person-group><year>2007</year><article-title>BTNL2, a butyrophilin/B7-like molecule, is a negative costimulatory molecule modulated in intestinal inflammation.</article-title><source>J Immunol</source><volume>178</volume><fpage>1523</fpage><lpage>1533</lpage><pub-id pub-id-type="pmid">17237401</pub-id></mixed-citation></ref><ref id="pone.0009723-Valentonyte1"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Valentonyte</surname><given-names>R</given-names></name><name><surname>Hampe</surname><given-names>J</given-names></name><name><surname>Huse</surname><given-names>K</given-names></name><name><surname>Rosenstiel</surname><given-names>P</given-names></name><name><surname>Albrecht</surname><given-names>M</given-names></name><etal/></person-group><year>2005</year><article-title>Sarcoidosis is associated with a truncating splice site mutation in BTNL2.</article-title><source>Nat Genet</source><volume>37</volume><fpage>357</fpage><lpage>364</lpage><pub-id pub-id-type="pmid">15735647</pub-id></mixed-citation></ref><ref id="pone.0009723-Clayton1"><label>19</label><mixed-citation publication-type="other"><person-group person-group-type="author"><name><surname>Clayton</surname><given-names>J</given-names></name><name><surname>Lonjou</surname><given-names>C</given-names></name><name><surname>Whittle</surname><given-names>D</given-names></name></person-group><year>1997</year><article-title>Allele and haplotype frequencies for HLA loci in various ethic groups.</article-title><person-group person-group-type="editor"><name><surname>Charron</surname><given-names>D</given-names></name><name><surname>Fauchet</surname><given-names>R</given-names></name><name><surname>Albert</surname><given-names>E</given-names></name><name><surname>Bodmer</surname><given-names>J</given-names></name><name><surname>Cambon-Thomsen</surname><given-names>A</given-names></name><etal/></person-group><fpage>665</fpage><lpage>820</lpage><comment>Genetic diversity of HLA, functional and medical implication. EDK, Paris</comment></mixed-citation></ref><ref id="pone.0009723-Evans1"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Evans</surname><given-names>TI</given-names></name><name><surname>Han</surname><given-names>J</given-names></name><name><surname>Singh</surname><given-names>R</given-names></name><name><surname>Moxley</surname><given-names>G</given-names></name></person-group><year>1995</year><article-title>The genotypic distribution of shared-epitope DRB1 alleles suggests a recessive mode of inheritance of the rheumatoid arthritis disease-susceptibility gene.</article-title><source>Arthritis Rheum</source><volume>38</volume><fpage>1754</fpage><lpage>1761</lpage><pub-id pub-id-type="pmid">8849347</pub-id></mixed-citation></ref><ref id="pone.0009723-Wakitani1"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wakitani</surname><given-names>S</given-names></name><name><surname>Imoto</surname><given-names>K</given-names></name><name><surname>Mazuka</surname><given-names>T</given-names></name><name><surname>Kim</surname><given-names>S</given-names></name><name><surname>Murata</surname><given-names>N</given-names></name><etal/></person-group><year>2001</year><article-title>Japanese generalised osteoarthritis was associated with HLA class I&#x02013;A study of HLA-A, B, Cw, DQ, DR in 72 patients.</article-title><source>Clin Rheumatol</source><volume>20</volume><fpage>417</fpage><lpage>419</lpage><pub-id pub-id-type="pmid">11771525</pub-id></mixed-citation></ref><ref id="pone.0009723-Sakkas1"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakkas</surname><given-names>LI</given-names></name><name><surname>Platsoucas</surname><given-names>CD</given-names></name></person-group><year>2007</year><article-title>The role of T cells in the pathogenesis of osteoarthritis.</article-title><source>Arthritis Rheum</source><volume>56</volume><fpage>409</fpage><lpage>424</lpage><pub-id pub-id-type="pmid">17265476</pub-id></mixed-citation></ref><ref id="pone.0009723-Mototani2"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mototani</surname><given-names>H</given-names></name><name><surname>Iida</surname><given-names>A</given-names></name><name><surname>Nakajima</surname><given-names>M</given-names></name><name><surname>Furuichi</surname><given-names>T</given-names></name><name><surname>Miyamoto</surname><given-names>Y</given-names></name><etal/></person-group><year>2008</year><article-title>A functional SNP in EDG2 increases susceptibility to knee osteoarthritis in Japanese.</article-title><source>Hum Mol Genet</source><volume>17</volume><fpage>1790</fpage><lpage>1797</lpage><pub-id pub-id-type="pmid">18325907</pub-id></mixed-citation></ref><ref id="pone.0009723-Pattrick1"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pattrick</surname><given-names>M</given-names></name><name><surname>Manhire</surname><given-names>A</given-names></name><name><surname>Ward</surname><given-names>AM</given-names></name><name><surname>Doherty</surname><given-names>M</given-names></name></person-group><year>1989</year><article-title>HLA-A, B antigens and alpha 1-antitrypsin phenotypes in nodal generalised osteoarthritis and erosive osteoarthritis.</article-title><source>Ann Rheum Dis</source><volume>48</volume><fpage>470</fpage><lpage>475</lpage><pub-id pub-id-type="pmid">2787142</pub-id></mixed-citation></ref><ref id="pone.0009723-Moos1"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moos</surname><given-names>V</given-names></name><name><surname>Menard</surname><given-names>J</given-names></name><name><surname>Sieper</surname><given-names>J</given-names></name><name><surname>Sparmann</surname><given-names>M</given-names></name><name><surname>Muller</surname><given-names>B</given-names></name></person-group><year>2002</year><article-title>Association of HLA-DRB1&#x0002a;02 with osteoarthritis in a cohort of 106 patients.</article-title><source>Rheumatology (Oxford)</source><volume>41</volume><fpage>666</fpage><lpage>669</lpage><pub-id pub-id-type="pmid">12048293</pub-id></mixed-citation></ref><ref id="pone.0009723-Lance1"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lance</surname><given-names>EM</given-names></name><name><surname>Kimura</surname><given-names>LH</given-names></name><name><surname>Manibog</surname><given-names>CN</given-names></name></person-group><year>1993</year><article-title>The expression of major histocompatibility antigens on human articular chondrocytes.</article-title><source>Clin Orthop Relat Res</source><fpage>266</fpage><lpage>282</lpage><pub-id pub-id-type="pmid">7684959</pub-id></mixed-citation></ref><ref id="pone.0009723-Sakata1"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakata</surname><given-names>M</given-names></name><name><surname>Masuko-Hongo</surname><given-names>K</given-names></name><name><surname>Nakamura</surname><given-names>H</given-names></name><name><surname>Onuma</surname><given-names>H</given-names></name><name><surname>Tsuruha</surname><given-names>JI</given-names></name><etal/></person-group><year>2003</year><article-title>Osteoarthritic articular chondrocytes stimulate autologous T cell responses in vitro.</article-title><source>Clin Exp Rheumatol</source><volume>21</volume><fpage>704</fpage><lpage>710</lpage><pub-id pub-id-type="pmid">14740448</pub-id></mixed-citation></ref><ref id="pone.0009723-Revell1"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Revell</surname><given-names>PA</given-names></name><name><surname>Mayston</surname><given-names>V</given-names></name><name><surname>Lalor</surname><given-names>P</given-names></name><name><surname>Mapp</surname><given-names>P</given-names></name></person-group><year>1988</year><article-title>The synovial membrane in osteoarthritis: a histological study including the characterisation of the cellular infiltrate present in inflammatory osteoarthritis using monoclonal antibodies.</article-title><source>Ann Rheum Dis</source><volume>47</volume><fpage>300</fpage><lpage>307</lpage><pub-id pub-id-type="pmid">3259125</pub-id></mixed-citation></ref></ref-list><fn-group><fn fn-type="conflict"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><fn fn-type="financial-disclosure"><p><bold>Funding: </bold>The Japanese study is supported by the Leading Project for Personalized Medicine in the Ministry of Education, Culture, Sports, Science and Technology. The European study is supported by Instituto de Salud Carlos III from the Spanish Health Ministry with participation of FEDER (Fondo Europeo para el Desarrollo Regional), the Foundation Mutua Madrile (Madrid). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p></fn></fn-group></back></article>